Navigation Links
Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results
Date:11/12/2007

/p>

Senior Director, Corporate Communications

Trubion Pharmaceuticals Inc.

(206) 838-0500

jdenike@trubion.com

Waggener Edstrom Healthcare

Jenny Moede

Senior Vice President

(503) 443-7000

jmoede@wagged.com

-FINANCIAL TABLES FOLLOW-

TRUBION PHARMACEUTICALS. INC.

STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(unaudited)

Three months ended Nine months ended

September 30, September 30,

2007 2006 2007 2006

Revenue $4,635 $16,539 $14,450 $30,175

Operating expenses:

Research and development 8,877 9,570 28,201 23,451

General and administrative 2,578 2,032 7,652 7,101

Total operating expenses 11,455 11,602 35,853 30,552

Income (loss) from operations (6,820) 4,937 (21,403) (377)

Interest income 1,120 419 3,582 1,389

Interest expense (213) (49) (566) (163)

Other income - 83 - 22

Net income (loss) $(5,913) $5,390 $(18,387) $871

Basic net income (loss) per share $(0.33) $3.79 $(1.04) $0.63

Diluted net income (loss) per share $(0.33) $0.40 $(1.04) $0.06

Shares used in computation of basic

net income (loss) per share 17,758 1,421 17,654 1,376

Shares used in computation of diluted

net income (loss) per share 17,758 13,245
'/>"/>

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Trubion Pharmaceuticals to Present at Upcoming Investor Conferences
2. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
11. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... On July 9 Prime Minister ... Russia,s first national "Industry" award ... is developing a unique project called MabNext . ... number of innovative drugs based on monoclonal antibodies for ... place at the International Exhibition "Innoprom 2014" in Ekaterinburg. ...
(Date:7/10/2014)... , July 10, 2014 Research ... addition of the "International Photonic Integrated Circuit ... Forecasts to 2019" report to their offering. ... The concept of photonic integration traces its ... century. The promise of photonic integration went unexplored ...
(Date:7/10/2014)... research may help in the fight against terrorism with ... quantities of explosives with the use of light and ... Sensors and Actuators B: Chemical , the researchers describe ... in concentrations as low as 6.3 ppm (parts per ... few minutes. , "Traditionally explosives detection has involved looking ...
(Date:7/10/2014)... the basis of psychiatric disorders has been extremely challenging ... risk but are insufficient to cause disease. Now investigators ... Press journal Cell Stem Cell describe a ... risks interact with other risk factors or environmental exposures ... research pinpoints a genetic variant that may predispose individuals ...
Breaking Biology Technology:Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Detecting trace amounts of explosives with light 2New strategy could uncover genes at the root of psychiatric illnesses 2
... Inc. (Xennex) announced today that it is collaborating ... with access to GeneCards(R) and associated proprietary tools, ... the advanced prototype of GeneCards(R) version 3.0, which ... utilizing GeneCards and the related technology for research ...
... in German . , The enzyme ... able to rapidly ,and efficiently detoxify chemical warfare agents ... subway attacks in 1995. A detailed understanding ,of the ... for efforts aiming to improve their properties. A group ...
... Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today ... on Thursday, April 23, 2009, after the U.S. financial ... on Thursday, April 23, 2009 at 5:00 p.m. Eastern ... results and highlights and to provide an update on ...
Cached Biology Technology:Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions 2Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions 3Structure of enzyme against chemical warfare agents determined 2Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results 2
(Date:7/11/2014)... Shenzhen, July 10, 2014---A team of researchers from The ... have identified a gene of wild soybean linked to ... to grow in saline soil. This study published online ... to unveil novel genomic information for crop improvement. , ... to domestication and human selection, cultivated soybeans have less ...
(Date:7/11/2014)... group members to reduce aggression and gain access to ... grooming activities shows a certain pattern across the day. ... Biology Letters . , Grooming between individuals in ... motives. To be groomed has hygienic benefits and is ... can provide access to infants, mating opportunities and high ...
(Date:7/11/2014)... Sweden, have explored two different ways that allow ... to the formation of oxygen molecules in photosynthesis. ... scientific journal Nature Communications . , "The ... catalysts for water oxidation, which are key components ... storage of solar energy in fuels like hydrogen, ...
Breaking Biology News(10 mins):BGI reports a novel gene for salt tolerance found in wild soybean 2Baboons groom early in the day to get benefits later 2Molecular snapshots of oxygen formation in photosynthesis 2
... team has brought powerful software to the never-ending arms ... and biochemists have developed and laboratory-tested a computer program ... that bacteria use to make natural antibiotics. ... known as the algorithm "K*" (pronounced K Star)-- is ...
... dioxide (CO2) distinguishes itself as the fastest growing greenhouse ... of CO2 emissions depends on our ability to measure ... of the increase. Until the late 1950s ... many questioned whether the industrial revolution and the associated ...
... gene variants associated with an increased incidence of hypertension ... and kidney failure. The report receiving early online release ... in genes for proteins involved with cardiovascular response to ... an association previously seen in animals but not demonstrated ...
Cached Biology News:Duke software dramatically speeds enzyme design 2Duke software dramatically speeds enzyme design 3Carbon accounting from atmospheric measurements -- the aircraft perspective 2Common gene variants increase risk of hypertension, may lead to new therapies 2
... containing a clone of the human Topoisomerase II ... alters the topological state of nucleic acids by ... break which generates a separate DNA helix (1,2) ... passage mechanism, the enzyme can relax negatively or ...
... Topo I, Wild Type Liquid. In ... DTT, 200 µM EDTA, 20% glycerol, pH 7.9. ... I) is a monomeric protein of 765 amino ... the relaxation of both positive and negative supercoiled ...
Request Info...
... RNA polymerase is a DNA-dependent RNA polymerase ... promoters. It efficiently synthesizes in vitro ... down stream from a T7 promoter. ... templates for in vitro translation, substrates in ...
Biology Products: